Vicora, a startup that’s working on a catheter system for the treatment of vascular disease such as pulmonary embolisms, deep vein thrombosis and stroke, recently raised a $3.6 million funding round.

Buffalo-based Vicora secures millions in funding to continue development of a new catheter system for treating vascular diseases. C-Level Executive Awards 2025 We're looking for world class ...

Microsoft Corp. expanded its deal to buy carbon removal credits from heat-plant operator Stockholm Exergi AB, increasing volumes first agreed last year by more than 50%. The agreement will now ...

Sometimes the simpler idea is the winner. That’s certainly the case with the winner of the Xprize Carbon Removal competition, which was announced on Wednesday. Mati Carbon walked away with the $ ...

A 67-year-old Turkish man began speaking Danish -- a language he had not used in years -- after suffering a brain blood clot and receiving emergency treatment in central Türkiye, doctors and ...

Designed for efficient clot removal in larger vessels, the device enhances procedural effectiveness while offering a streamlined approach to treating thrombotic occlusions. As demand grows for ...

the latest in a suite of Pounce Thrombectomy systems that provide rapid endovascular removal of acute or chronic clot from peripheral arteries. Intended for removal of thrombi and emboli from ...

Symphony Thrombectomy System is designed to efficiently maximize clot removal with a focus on minimizing blood loss Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA ...

The Symphony Thrombectomy System has introduced precision thrombectomy to the market, and we are confident it will deliver faster, safer and more precise clot removal that will ultimately benefit ...

"You can erase this, but you cannot erase our history," a Kappa Alpha Psi member said as a group bid goodbye to Black Lives Matter Plaza in D.C., a day before the removal process began Monday.

Meeting the minimum requirement for vitamin B12, needed to make DNA, red blood cells and nerve tissue, may not actually be enough – particularly if you are older. It may even put you at risk for ...